Clinical Trials Logo

Clinical Trial Summary

The present study aims at evaluating whether treatment with two different drugs, Ibrutinib and Rituximab is both efficient and safe for newly diagnosed patients with chronic lymphocytic leukemia.


Clinical Trial Description

Given that: - Ibrutinib as single agent has been associated with a high response rate and PFS in previously treated patients, and in patients with poor prognosis clinical and biologic features. - Ibrutinib as single agent has proven activity and is associated with a good safety profile in elderly patients with CLL. - The Ibrutinib plus Rituximab combination has been associated with a high response rate and PFS in previously treated patients, and in patients with poor prognosis clinical and biologic features. - The combined administration of Ibrutinib and Rituximab could be an effective and safe front-line treatment schedule for unfit patients with CLL. - The current study is designed to evaluate whether first line treatment with Ibrutinib and Rituximab results in a significant improvement in PFS at 12 months as compared with chlorambucil plus rituximab in patients unfit for fludarabine- or bendamustine-based treatments. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02232386
Study type Interventional
Source Gruppo Italiano Malattie EMatologiche dell'Adulto
Contact
Status Active, not recruiting
Phase Phase 2
Start date March 2, 2015
Completion date April 2024

See also
  Status Clinical Trial Phase
Terminated NCT05291897 - First choIce Antidepressants: General Practitioner's Treatment Approach in the Czech Republic
Completed NCT02063763 - TPO-mimetics Before Splenectomy in Adult Primary Immune Thrombocytopenia Patients.
Not yet recruiting NCT01785654 - Hemodynamic and Biological Evaluations During Reventilation Collapse in ICU N/A
Recruiting NCT02200159 - Predictive Factors of Failure or Success of Sedation With Dexmedetomidine in ICU N/A
Completed NCT01888094 - SUBclavian Central Venous Catheters Guidance and Examination by UltraSound Phase 2/Phase 3
Completed NCT01957020 - Stereotactic Directional Vacuum-Assisted Breast Biopsy N/A
Recruiting NCT03282331 - Lung MORphological Modifications Evaluated by Electrical Impedance Tomography During Preoxygenation for the Intubation of Hypoxemic Patients: Comparison of Standard Oxygenation, High Flow Nasal Oxygen Therapy, and NonInvasive Ventilation (MORPHEIT Study, an Ancillary Study of PREONIV Trial) N/A
Completed NCT03203967 - Epidural Morphine for Postoperative Analgesia After Total Knee Arthroplasty N/A
Enrolling by invitation NCT05643105 - Anastomotic Leakage After Colon Cancer Surgery
Completed NCT02202720 - Evaluation of Richmond Agitation Sedation Scale According to Alveolar Concentration of Sevoflurane During a Sedation With Sevoflurane in ICU Patients Phase 2
Completed NCT04206306 - Functional Recovery Over the First Year After ICU Discharge
Recruiting NCT01782430 - PREoxygenation for the Intubation of Hypoxemic Patients: Comparison of Standard Oxygenation, High Flow Nasal Oxygen Therapy, and NonInvasive Ventilation Phase 2/Phase 3